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I N T R O D U C T I O N
In the mammalian heart, -adrenergic stimulation acti-
vates PKA coupled with a rise of cAMP, resulting in phos-
phorylation of several membrane- and sarcomere-based 
proteins in the cardiomyocyte (for reviews with original 
citations see Bers, 2001, 2002). Accordingly, myocardial 
function is associated with increased developed force 
and increased rates of rise and fall of developed force. It 
is generally considered that changes in the intracellular 
Ca
2+ concentration are primarily responsible for these 
effects (Kurihara and Konishi, 1987; Endoh and Blinks, 
1988; Li et al., 2000; Bers, 2001, 2002). In the sarcomere, 
PKA principally targets the thin filament protein troponin 
(Tn)I, the thick filament protein myosin-binding pro-
tein C (MyBP-C) (e.g., Bers, 2001, 2002), and the giant 
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elastic protein titin (connectin) (Yamasaki et al., 2002; 
Fukuda et al., 2005, 2008). Phosphorylation of cardiac 
TnI (cTnI) and MyBP-C has been reported to decrease 
myofibrillar Ca
2+ sensitivity and to enhance cross-bridge 
cycling, which likely contributes to the increased rate of 
relaxation and decreased twitch duration (Hoh et al., 
1988; Hongo et al., 1993; Kentish et al., 2001). Diastolic 
properties are also affected during -adrenergic stimu-
lation, with a reduction in myocardial stiffness due to 
titin phosphorylation at the N2B segment in the I-band 
(both N2B and N2BA titins: Yamasaki et al., 2002; Fukuda 
et al., 2005, 2008).
Because cardiac myofilaments are activated by Ca
2+ in 
a graded fashion, in the range of the submaximal Ca
2+ 
concentration, the relationship between the Ca
2+ con-
centration  and  active  force  is  of  fundamental  impor-
tance (Bers, 2001, 2002). In this process, Tn switches the 
thin filament state to “off” or “on” (two-state model; e.g., 
Solaro and Rarick, 1998), or to “blocked, “closed,” or 
“open” (three-state model; e.g., Gordon et al. 2000). Tn 
is a heterotrimer of the following distinct gene products: 
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Protein kinase A (PKA)-dependent phosphorylation of troponin (Tn)I represents a majﾭor physiological mecha-
nism during -adrenergic stimulation in myocardium for the reduction of myofibrillar Ca
2+ sensitivity via weaken-
ing of the interaction with TnC. By taking advantage of thin filament reconstitution, we directly investigated 
whether or not PKA-dependent phosphorylation of cardiac TnI (cTnI) decreases Ca
2+ sensitivity in different types 
of muscle: cardiac (porcine ventricular) and fast skeletal (rabbit psoas) muscles. PKA enhanced phosphorylation 
of cTnI at Ser23/24 in skinned cardiac muscle and decreased Ca
2+ sensitivity, of which the effects were confirmed 
after reconstitution with the cardiac Tn complex (cTn) or the hybrid Tn complex (designated as PCRF; fast skele-
tal TnT with cTnI and cTnC). Reconstitution of cardiac muscle with the fast skeletal Tn complex (sTn) not only 
increased Ca
2+ sensitivity, but also abolished the Ca
2+-desensitizing effect of PKA, supporting the view that the phos-
phorylation of cTnI, but not that of other myofibrillar proteins, such as myosin-binding protein C, primarily 
underlies the PKA-induced Ca
2+ desensitization in cardiac muscle. Reconstitution of fast skeletal muscle with cTn 
decreased Ca
2+ sensitivity, and PKA further decreased Ca
2+ sensitivity, which was almost completely restored to the 
original level upon subsequent reconstitution with sTn. The essentially same result was obtained when fast skeletal 
muscle was reconstituted with PCRF. It is therefore suggested that the PKA-dependent phosphorylation or dephos-
phorylation of cTnI universally modulates Ca
2+ sensitivity associated with cTnC in the striated muscle sarcomere, 
independent of the TnT isoform.
© 2009 Matsuba et al.  This article is distributed under the terms of an Attribution–Non-
commercial–Share Alike–No Mirror Sites license for the first six months after the publication 
date (see http://www.jgp.org/misc/terms.shtml). After six months it is available under a Cre-
ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as 
described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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strips (1–2 mm in diameter and 10 mm in length) were dis-
sected from the papillary muscle of the left ventricle in Ca
2+-free 
Tyrode’s solution (see Terui et al., 2008 for composition contain-
ing 30 mM 2,3-butanedione monoxime [BDM] to inhibit actomy-
osin interaction), with 10 µM propranolol to block nonspecific 
-adrenergic  stimulation  and  10  µM  carbamoylcholine  to  en-
hance phosphatase activity (Gupta et al., 1994). BDM is also 
known to enhance dephosphorylation of myofibrillar proteins 
(Venema et al., 1993; Turnbull et al., 2002), including cTnI and 
MyBP-C. The presence of propranolol, carbamoylcholine, and 
BDM, however, does not exclude basal levels of protein phos-
phorylation (Fukuda et al., 2005 and this study). Psoas muscles 
were obtained from white rabbits (2–3 kg). The muscle strips 
were skinned in relaxing solution (5 mM MgATP, 40 mM N,N-bis 
(2-hydroxy-ethyl)-2-aminoethanesulfonic acid [BES], 1 mM Mg
2+, 
10 mM EGTA, 1 mM dithiothreitol, 15 mM phosphocreatine, 
15 U/ml creatine phosphokinase, and 180 mM ionic strength 
[adjﾭusted by K-propionate], pH 7.0) containing 1% (wt/vol) Tri-
ton X-100 and 10 mM BDM overnight at 3°C. They were stored 
for up to 3 wk at 20°C in relaxing solution containing 50% (vol/
vol) glycerol. All solutions contained protease inhibitors (0.5 mM 
PMSF, 0.04 mM leupeptin, and 0.01 mM E64) to avoid protein 
degradations (see Fukuda et al., 2003).
Skinned muscle mechanics
Isometric force was measured at 15°C based on our previous 
reports with either thin cardiac bundles (porcine left ventricular 
[PLV]; 100 µm in diameter and 2 mm in length; see Terui et al., 
2008) or single skeletal fibers (rabbit psoas [RP]; see Udaka et al., 
2008). In brief, sarcomere length (SL) was measured by laser dif-
fraction during relaxation (as in Fukuda et al., 2000, 2001a,b) 
and set at 2.0 µm for both PLV and RP. To avoid the possible 
effects  of  PKA-dependent  passive  force  modulation  on  active 
force, we conducted all experiments at SL 2.0 µm, where passive 
force is barely produced in both PLV and RP (e.g., Cazorla et al., 
2000; Prado et al., 2005; Terui et al., 2008). Just before contrac-
tion, the preparation was immersed in low-EGTA (0.5 mM) relax-
ing solution to avoid slowing of contraction (Fukuda et al., 2001a). 
The preparation was first activated at pCa 4.5 to obtain maximal 
Ca
2+-activated force, followed by relaxation. The preparation was 
then activated at various pCa’s (from high to low pCa, and lastly at 
pCa 4.5) to construct the force-pCa curve (i.e., force-pCa proto-
col). The curves were fitted to the Hill equation, and the value of 
the midpoint of the force-pCa curve (i.e., pCa50) was used as an 
index of myofibrillar Ca
2+ sensitivity (Fukuda et al., 2000). The 
Hill coefficient (nH) was used as an index of thin filament cooper-
ative activation (Fukuda et al., 2000). Here, forces at submaximal 
Ca
2+ levels were normalized to the maximal force obtained at the 
end of the force-pCa protocol (rundown in active force during 
the protocol was <10%). With the values of pCa50, nH, and maximal 
force being similar in the presence of a higher concentration of cre-
atine phosphokinase (225 U/ml; not depicted), we used 15 U/ml 
throughout the study for both PLV and RP.
Next, the preparation was incubated for 50 min at 22°C with 
purified PKA (catalytic subunit from bovine heart; Sigma-Aldrich) 
at a concentration of 1 U/µl (Fukuda et al., 2005). PKA-specific 
inhibitor (PKI; Sigma-Aldrich) was used in control experiments at 
50 µM (Fukuda et al., 2005). Then, the force-pCa protocol was 
repeated and the force-pCa curve was obtained. The difference 
between the values of pCa50 (pCa50) before and after PKA treat-
ment was used as an index of the PKA-induced Ca
2+ desensitiza-
tion (PKA effect).
To  reduce  the  background  phosphorylation  of  myofibrillar 
proteins, we used protein phosphatase 1 (PP1; Sigma-Aldrich) 
(see Jideama et al., 2006). After conducting the force-pCa proto-
col, cardiac muscle preparations were immersed in relaxing solu-
tion  containing  PP1  at  900  U/ml  for  1  h  at  25°C.  Then,  the 
i.e., TnC (a Ca
2+ receptor), TnI (an inhibitor of actomy-
osin interaction), and TnT (an anchor that binds to tropo-
myosin [Tm]) (e.g., Solaro and Rarick, 1998; Ohtsuki 
and Morimoto, 2008). The cardiac isoform of TnI has a 
far N-terminal extension consisting of 30 amino acids, 
which is unique to this molecule (e.g., Solaro and Rarick, 
1998). It is well documented that two Ser residues (Ser23 
and Ser24) in the N-terminal extension are phosphory-
lated by PKA, resulting in enhanced relaxation via a 
decrease in myofibrillar Ca
2+ sensitivity (for review see 
Solaro and Rarick, 1998; Layland et al., 2005). Recently, 
Howarth et al. (2007) demonstrated a clear conforma-
tional transition in the cardiac Tn complex (cTn) upon 
Ser23/24 phosphorylation in cTnI. They proposed that 
Ser23/24 phosphorylation extends and stabilizes the 
C-terminal helix in the N-terminal extension of cTnI, 
and weakens interactions with the N-lobe of cTnC. This 
may result in bending of cTnI and positioning of the 
acidic N terminus for electrostatic interactions with the 
electrostatic inhibitory region of cTnI. Skeletal TnI, 
from either fast or slow muscle, does not possess PKA 
phosphorylation  sites  in  the  N-terminal  region  and, 
therefore, does not exhibit a decrease in Ca
2+ sensitivity 
upon PKA treatment (e.g., Solaro and Rarick, 1998). 
Indeed, it has been reported that cardiac muscle from 
a mouse model expressing slow skeletal TnI in the heart 
does not exhibit a decrease in Ca
2+ sensitivity when 
exposed to -adrenergic stimulation (Fentzke et al., 
1999). More recent studies using mutant forms of cTnI 
with either pseudo-phosphorylated PKA sites (cTnI-S23D, 
S24D) or nonphosphorylatable mutant cTnI-S23A, S24A 
strongly support a critical role of cTnI in cardiac con-
tractility during -adrenergic stimulation (for review see 
Solaro et al., 2008).
Here, we tested whether the PKA-dependent control 
of phosphorylation or dephosphorylation of cTnI mod-
ulates Ca
2+ sensitivity in different types of muscle by   
using our Tn reconstitution technique (Terui et al., 2008). 
We found that PKA decreases Ca
2+ sensitivity not only in 
cardiac muscle, but also in fast skeletal muscle after thin 
filaments had been reconstituted with cTn or the hybrid 
Tn complex (PCRF) consisting of cTnI and cTnC and 
fast skeletal TnT (sTnT). Our findings demonstrate a 
universal role of cTnI via PKA activation in the modula-
tion of Ca
2+ sensitivity associated with cTnC in the stri-
ated muscle sarcomere.
M AT E R I A L S   A N D   M E T H O D S
All experiments performed in this study conform to the Guide for 
the Care and Use of Laboratory Animals (1996. National Acad-
emy of Sciences, Washington D.C.).
Preparation of skinned muscles
Skinned cardiac muscles were prepared based on our recent arti-
cle (Terui et al., 2008). In brief, porcine hearts (animals, 1.0 
years  old)  were  obtained  from  a  local  slaughterhouse.  Muscle   Matsuba et al. 573
Western blotting
Immunoblotting was performed based on our previous report 
(O-Uchi et al., 2008). After separation on 20% SDS-PAGE, pro-
teins were transferred to a polyvinylidene difluoride membrane. 
For the detection of PKA-dependent Ser23/24 phosphorylation 
in cTnI (pig cTnI; GenBank accession no. DQ534449.1), the 
transferred membranes were blocked by Blocking One-P solution 
(Nakalai Tesque, Inc.), which is free of phosphate groups and 
endogenous phosphates, and incubated with cardiac phospho-
TnI (Ser23/24) polyclonal antibody (Cell Signaling Technology). 
Then, the membranes were incubated with horseradish peroxi-
dase–conjﾭugated secondary antibody (GE Healthcare), and the 
bands were visualized by using an ECL-plus detection kit (GE 
Healthcare).  Sequentially,  after  gently  stripping  these  primary 
and secondary antibodies to allow reprobings on the same mem-
brane, the membranes were blocked by Tris-based buffer contain-
ing  5%  nonfat  skim  milk  (BD)  and  0.1%  tween-20.  For  the 
detection of total cTnI, we used anti-cTnI monoclonal antibody 
(Millipore)  and  secondary  horseradish  peroxidase–conjﾭugated 
antibody (GE Healthcare). Radiographs were scanned and digi-
tized (ES-2200; Epson), and densitometry was performed using 
One-D-Scan (v. 2.03; BD).
Statistics
Significant differences were assigned using the paired or unpaired 
Student’s t test as appropriate. Data are expressed as mean ± SEM, 
with “n” representing the number of muscles. Statistical signifi-
cance was assumed to be P < 0.05. “N.S.” indicates P > 0.05.
Online supplemental material
Table S1 shows the reproducibility of the values of pCa50, nH, and 
maximal force after repeated measurements of the force-pCa curve 
in PLV and RP under the control condition with no treatment.   
Fig. S1 shows that (1) PKA phosphorylates MyBP-C in PLV, and   
(2) cTnI is the only protein among various Tn subunits that shows   
phosphorylation upon PKA treatment. Table S1 and Fig. S1 are avail-
able at http://www.jﾭgp.org/cgi/content/full/jﾭgp.200910206/DC1.
RESULTS
Effect of PKA on Ca
2+ sensitivity in PLV muscle  
with and without sTn reconstitution
First, we tested how PKA-dependent phosphorylation of 
cTnI modulates Ca
2+ sensitivity in PLV under the control 
condition without Tn reconstitution. We found that our 
PKA treatment nearly doubled Ser23/24 phosphoryla-
tion in cTnI (Fig. 1 A). Fig. 1 B shows the effect of PKA 
on myofibrillar Ca
2+ sensitivity. Consistent with a previ-
ous study on porcine ventricular preparations (Zhang   
et al., 1995), the force-pCa curve was shifted to the right by 
0.10 ± 0.01 pCa units (as indexed by pCa50), exhibiting a   
decrease in Ca
2+ sensitivity. PKA did not affect maximal 
force or thin filament cooperative activation (as indexed 
by nH; Table I). Ca
2+ desensitization was not observed 
when the preparation was treated with PKA in the pres-
ence of the PKI (pCa50: 5.57 ± 0.02 and 5.54 ± 0.03, 
respectively, before and after PKA+PKI; P > 0.05; n = 6).
Next, we tested the effect of PKA on Ca
2+ sensitivity 
in PLV after reconstitution with sTn (Fig. 1 C). Quasi-
complete  reconstitution  with  sTn  (for  60  min)  in-
creased Ca
2+ sensitivity by 0.31 ± 0.03 pCa units (see 
preparations were immersed in normal relaxing solution at 15°C 
for 10 min with gentle agitation to remove PP1 for subsequent 
PKA treatment.
Tn extraction
The fast skeletal Tn complex (sTn) was purified from rabbit fast 
skeletal  muscle  based  on  our  previously  published  procedure 
(Shiraishi et al., 1993) and stored at 80°C.
Porcine ventricular and rabbit fast skeletal Tn subunits were 
prepared by the method of Ojﾭima and Nishita (1986), with slight 
modifications. In brief, Tn components were separated by the 
two-step ion-exchange chromatography in the presence of 6 M 
urea and 1 mM EDTA, with Toyopearl DEAE-650M and CM-650M 
(Tosoh) columns (2.0 cm i.d. × 20 cm) (see Ojﾭima and Nishita, 
1988 for details). To reconstitute the cardiac Tn and sTnT-substi-
tuted Tn, the three Tn components (60 µM final of each) were 
mixed at a 1:1:1 molar ratio and dialyzed as follows: (1) The mix-
tures were dialyzed for 3 h against 6 M urea, 0.5 M KCl, 10 mM 
Tris-HCl, pH 7.6, and 5 mM 2-mercaptoethanol. (2) The concen-
tration of urea in the outer dialysate was decreased stepwise to 3 
and 1 M. (3) The urea was removed by dialysis for 6 h against 0.5 
M KCl, 10 mM Tris-HCl, pH 7.6, 2 mM MgCl2, 0.1 mM CaCl2, 
0.01% NaN3, and 5 mM 2-mercaptoethanol. (4) The KCl concen-
tration of the outer dialysate was decreased stepwise to 0.25 and 
0.15 M. The precipitate formed was removed by centrifugation 
(10,000 g, 15 min). The reconstituted Tn complexes were concen-
trated by centrifugal ultrafiltration with an Apollo concentrator 
(Orbital Biosciences) and finally dialyzed against 1 mM NaHCO3 
and 5 mM 2-mercaptoethanol. Reconstituted Tn complexes were 
stored at 80°C.
Tn exchange
Tn exchange was performed based on our previously published 
procedure (Terui et al., 2008). In brief, after performing the force-
pCa  protocol  without  any  treatment  (as  described  above),  the 
skinned muscle preparation, either PLV or RP, was bathed in rigor 
solution (10 mM BES, 150 mM K-propionate, 2.5 mM EGTA, and 
5 mM MgCl2, pH 7.0) containing cTn or PCRF (2 and 6 mg/ml for 
PLV and RP, respectively) and 80 mM BDM for 60 min at 25°C. sTn 
reconstitution was performed on PLV at 2 mg/ml for 20, 40, or 
60 min at 25°C (60 min for quasi-complete reconstitution; see Terui 
et al., 2008). The time-dependent change in cTnI upon sTn recon-
stitution was assessed using the ratio cTnI/(cTnI + sTnI). As noted 
in our previous report (Terui et al., 2008), the presence of BDM 
was essential to avoid contraction upon exchange and the ensuing 
damage  to  the  sarcomere  structure.  Next,  the  preparation  was 
washed with normal relaxing solution at 15°C for 10 min with gen-
tle agitation to remove excess Tn molecules. In experiments with 
cTn- or PCRF-reconstituted RP, the fibers were further treated with 
sTn at 2 mg/ml for 60 min at 25°C after PKA treatment.
Electrophoresis
SDS-PAGE was performed based on our previous studies (Terui 
et al., 2008; Udaka et al., 2008). Muscle preparations were solubi-
lized and electrophoresed on Laemmli gels (acrylamide, 3.5% in 
stack and 15% resolving gel, pH 9.3; stained with Coomassie bril-
liant  blue).  Tn  isoforms  were  identified  by  commigration  with 
known standards, as performed in our previous study (Terui et al., 
2008). We quantified the reconstitution ratio by comparing the ra-
tio of TnI or TnT to actin with that obtained for the original muscle 
(i.e., either RP or PLV muscle). Due to the technical difficulty in 
the quantitative analysis of TnC, especially in RP where cTnC and 
sTnC coexist after reconstitution (with only a slight difference in 
molecular weight), we present only the analyzed data on TnT and 
TnI, based on our previous study (Terui et al., 2008).574 THIN FILAMENT RECONSTITUTION AND PKA PHOSPHORYLATION
Effect of PKA on Ca
2+ sensitivity in PLV muscle 
reconstituted with cTn or PCRF
Next, we tested whether or not PKA exerts its Ca
2+-de-
sensitizing effect in PLV after thin filament reconstitu-
tion  with  cTn  or  PCRF.  The  representative  15%  gel 
showed that the band for cTnT or cTnI was unaffected 
by cTn reconstitution (cTn reconstitution ratio: cTnI, 
94.21 ± 9.63%; cTnT, 93.22 ± 5.33%; n = 6) (Fig. 2 A; see 
Terui et al., 2008). Upon PCRF reconstitution, endoge-
nous cTnT was effectively replaced by sTnT, with cTnI 
appearing similarly as in control PLV (PCRF reconstitu-
tion ratio: cTnI, 86.79 ± 8.81%; sTnT, 130.28 ± 4.09%; 
residual cTnT, 4.91 ± 1.62%; n = 6) (Fig. 2 A). Western 
blotting demonstrated that cTnI Ser23/24 phosphory-
lation  was  clearly  less  in  cTn-  or  PCRF-reconstituted 
PLV than in control PLV, and that PKA treatment in-
creased the phosphorylation level in both (Fig. 2 B; see 
legend for quantitative analysis).
As with sTn reconstitution (Table I; see also Terui 
et al., 2008), maximal force was decreased by a small 
magnitude (5%) upon cTn or PCRF reconstitution in 
PLV (Table II). However, the decrease was not statisti-
cally  significant  and,  therefore,  we  consider  that  the 
damage, if at all, to the sarcomere structure (or the reg-
ulatory system) was minimal in our protocol, as reported 
in our earlier study (Terui et al., 2008).
Terui et al., 2008) and completely abolished the PKA-
induced Ca
2+ desensitization. Increasing the time for 
sTn reconstitution (up to 60 min) increased Ca
2+ sen-
sitivity (Fig. 1 D, left) and diminished the PKA effect 
(Fig. 1 D, middle), both in a linear fashion. A linear 
relationship was found between the residual amount 
of cTnI and the PKA effect (Fig. 1 D, right).
Figure 1.  Effects of PKA on cTnI phos-
phorylation and Ca
2+ sensitivity in PLV. 
(A;  Top)  Western  blotting  showing 
cTnI  phosphorylation  (12.5  µg  pro-
tein/well). Cont., control without PKA 
treatment.  (Bottom)  Comparison  of 
the  intensity  of  cTnI  Ser23/24  phos-
phorylation normalized with total cTnI 
content  in  control  and  PKA-treated 
PLV. *, P < 0.05. n = 3. (B) Force-pCa 
curves  showing  the  effect  of  PKA  on 
Ca
2+  sensitivity.  (Inset)  pCa50  values 
before  and  after  PKA  treatment.  *, 
P < 0.05. n = 7. (C) Force-pCa curves 
showing the effects of quasi-complete 
sTn reconstitution (shown in gray) and 
subsequent treatment with PKA on Ca
2+ 
sensitivity. (Inset) pCa50 values. *, P < 
0.05. n = 7. (D; Left) Plot of sTn treat-
ment time versus sTn-induced shift of 
pCa50. (Middle) Plot of sTn treatment 
time versus PKA-induced shift of pCa50. 
(Right) Plot of residual cTnI ratio (i.e., 
cTnI/(cTnI  +  sTnI))  versus  PKA-in-
duced shift of pCa50. n = 7.
TA B L E   I
Summary of the values of maximal active force and nH before and after 
PKA treatment in PLV
Maximal force 
(mN/mm
2)
nH
Fig. 1 B
Control PLV 52.89 ± 3.24 4.06 ± 0.20
PKA 52.23 ± 3.70 4.02 ± 0.22
Control PLV 51.89 ± 3.16 3.98 ± 0.21
PKA + PKI 50.23 ± 3.78 3.97 ± 0.18
Fig. 1 C
Control PLV 52.06 ± 3.77 3.74 ± 0.24
sTn 47.71 ± 4.59 3.87 ± 0.09
sTn + PKA 46.92 ± 4.85 3.84 ± 0.12
Maximal force was obtained by activating muscle at pCa 4.5 before plotting 
of the force-pCa curve at each condition. No significant difference was 
observed in each case.  Matsuba et al. 575
by 0.09 ± 0.01 pCa units upon PCRF reconstitution, and 
it was decreased by 0.18 ± 0.01 pCa units after PKA treat-
ment (Fig. 2 D). Accordingly, the PKA effect was more pro-
nounced with exogenous cTnI (compare with Fig. 1 B). 
Reconstitution with cTn or PCRF did not significantly 
affect the maximal force or nH (Table II).
Effect of PKA on Ca
2+ sensitivity in PP1-treated PLV muscle
The apparently greater effect of PKA on Ca
2+ sensitivity 
in cTn- or PCRF-reconstituted PLV (Fig. 2, C and D) may 
be coupled with reconstitution of the dephosphorylated 
form of cTnI and, therefore, a greater magnitude of PKA-
dependent phosphorylation of it. We therefore tested 
the effect of PKA on Ca
2+ sensitivity in PLV that had been 
pretreated with PP1 to reduce background phosphoryla-
tion of cTnI. Consistent with a previous report (Jideama 
et al., 2006), PP1 effectively reduced background cTnI 
Ser23/24  phosphorylation,  and  the  subsequent  PKA 
treatment increased the phosphorylation level (Fig. 3 A; 
see legend for quantitative analysis).
Ca
2+ sensitivity was slightly but significantly (0.09 ± 0.01 
pCa units) increased upon PP1 treatment, with no   
significant change in maximal force or nH (Table II), 
and it was decreased by 0.18 ± 0.01 pCa units after PKA 
treatment. Fig. 3 C compares the magnitude of Ca
2+  
sensitization upon PP1 treatment, cTn, and PCRF re-
constitution, and the subsequent PKA effect obtained 
in these preparations. All maneuvers similarly increased 
Ca
2+ sensitivity was slightly but significantly (0.07 ± 
0.01 pCa units) increased upon cTn reconstitution, and 
it was decreased by 0.16 ± 0.01 pCa units after PKA treat-
ment (Fig. 2 C). Similarly, Ca
2+ sensitivity was increased 
Figure 2.  Effects of PKA on cTnI phos-
phorylation and Ca
2+ sensitivity in PLV   
reconstituted  with  cTn  or  PCRF.   
(A; Left) SDS-PAGE for control, cTn-, 
and PCRF-reconstituted PLV. Cont., con-
trol with no reconstitution; cTn, cTn re-
constitution; PCRF, PCRF reconstitution; 
Tm, tropomyosin; LC-1, myosin light 
chain 1; LC-2, myosin light chain 2.   
(B) Western blotting showing the effect 
of PKA on cTnI Ser23/24 phosphory-
lation in cTn- and PCRF-reconstituted 
PLV  (12.5  µg  protein/well).  Cont., 
control with no treatment. Normalized   
intensity compared with control (n = 3): 
cTn,  10.12  ±  6.53%;  PCRF,  13.83  ± 
5.23%; cTn + PKA (PKA phosphoryla-
tion after cTn reconstitution), 214.94 ± 
30.82% (P < 0.05 compared with cTn); 
PCRF  +  PKA  (PKA  phosphorylation   
after PCRF reconstitution), 228.89 ±   
20.13%  (P  <  0.05  compared  with 
PCRF). (C) Force-pCa curves showing 
the  effects  of  cTn  reconstitution  and 
subsequent PKA treatment on Ca
2+ sen-
sitivity. (Inset) Difference between the 
values of the PKA-induced shift of pCa50 (C, control minus cTn + PKA; cTn, cTn minus cTn + PKA). *, P < 0.05. n = 7. (D) Force-pCa 
curves showing the effects of PCRF reconstitution and subsequent PKA treatment on Ca
2+ sensitivity. (Inset) Difference between the 
values of the PKA-induced shift of pCa50 (C, control minus PCRF + PKA; PCRF, PCRF minus PCRF + PKA). *, P < 0.05. n = 7. PKA treat-
ment did not significantly affect maximal force or nH in both C and D (see Table II).
TA B L E   I I
Summary of the values of maximal active force, pCa50 and nH before and 
after PKA treatment in PLV after reconstitution with cTn or PCRF or 
treatment with PP1
Maximal force 
(mN/mm
2)
pCa50 nH
Fig. 2 C
Control PLV 55.99 ± 5.92 5.55 ± 0.01 4.23 ± 0.25
cTn 52.52 ± 5.48 5.62 ± 0.01
a 4.15 ± 0.35
cTn+PKA 51.17 ± 5.42 5.46 ± 0.01
a,b 4.56 ± 0.30
Fig. 2 D
Control PLV 53.85 ± 6.03 5.55 ± 0.02 4.16 ± 0.16
PCRF 51.42 ± 5.35 5.64 ± 0.03
a 3.69 ± 0.16
PCRF + PKA 49.86 ± 5.32 5.46 ± 0.01
a,b 3.92 ± 0.18
Fig. 3 B
Control PLV 59.32 ± 4.51 5.55 ± 0.01 4.12 ± 0.16
PP1 56.47 ± 5.70 5.64 ± 0.02
a 4.24 ± 0.35
PP1 + PKA 54.10 ± 5.66 5.46 ± 0.01
a,b 4.05 ± 0.20
Maximal force was obtained by activating muscle at pCa 4.5 before plotting 
of the force-pCa curve at each condition.
aP < 0.05 compared with the corresponding values for control PLV (before 
thin filament reconstitution or PP1 treatment).
bP  <  0.05  compared  with  the  corresponding  values  for  thin  filament 
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Effect of PKA on Ca
2+ sensitivity in PCRF-reconstituted  
RP muscle
Finally, by using PCRF reconstitution, we investigated 
whether the PKA-induced decrease in Ca
2+ sensitivity in 
cTn-reconstituted RP is coupled with the phosphoryla-
tion of cTnI or, alternatively, cTnT. As shown in Fig. 5 A, 
our protocol with PCRF allowed for 50% replacement 
of  sTnI  with  cTnI  (PCRF  reconstitution  ratio:  cTnI, 
47.80 ± 2.54%; sTnT, 128.52 ± 8.80%; residual sTnI, 
43.52 ± 6.51%; n = 6). Subsequent treatment with sTn 
Ca
2+ sensitivity (Fig. 3 C, left; P > 0.05), and the subse-
quent PKA effect was similar (Fig. 3 C, right; P > 0.05).
Effect of PKA on Ca
2+ sensitivity in cTn-reconstituted  
RP muscle
We next investigated whether PKA exerts its Ca
2+-desen-
sitizing effect in RP after cTn reconstitution (reconstitu-
tion ratio, 50%; see Terui et al., 2008). As shown in 
the chart recording (Fig. 4 A), submaximal forces (at 
pCa 6.0 and 5.75) were decreased upon cTn reconstitu-
tion by a magnitude greater than that of maximal force, 
resulting in a decrease in the percentage to the maxi-
mum (see Terui et al., 2008). PKA treatment further 
decreased submaximal forces with little or no change in 
maximal force. Lastly, sTn reconstitution restored sub-
maximal forces to levels similar to those obtained 
before cTn reconstitution, accompanied by a slight in-
crease in maximal force.
Force-pCa curves in Fig. 4 B demonstrate that Ca
2+ 
sensitivity is decreased by 0.10 ± 0.01 pCa units with cTn 
reconstitution (see Terui et al., 2008) and is further 
decreased by 0.10 ± 0.01 pCa units with PKA treatment. 
As evident in the chart recording (Fig. 4 A), sTn recon-
stitution almost completely restored Ca
2+ sensitivity to 
the original level before cTn reconstitution. In a con-
trol experiment without cTn reconstitution, PKA treat-
ment did not affect Ca
2+ sensitivity in RP (Fig. 4 C).
Maximal force and nH were decreased by cTn recon-
stitution (Terui et al., 2008), but not by PKA treatment, 
and both were restored with sTn reconstitution to levels 
not significantly different than those obtained before 
cTn reconstitution (Table III).
Figure 3.  Effects of PKA on cTnI phosphory-
lation and Ca
2+ sensitivity in PP1-treated PLV. 
(A)  Western  blotting  showing  the  effect  of 
PP1 or PKA on the phosphorylation level of 
Ser23/24  in  cTnI  (12.5  µg  protein/well). 
Cont.,  control  with  no  treatment.  Normal-
ized intensity compared with control (n = 5): 
PP1, 40.16 ± 10.48%; PP1 + PKA (PKA phos-
phorylation  after  PP1  treatment),  207.76  ±   
53.85%  (P  <  0.05  compared  with  PP1).   
(B) Force-pCa curves showing the effects of PP1 
and subsequent PKA treatment on Ca
2+ sen-
sitivity. (Inset) Difference between the values 
of  the  PKA-induced  shift  of  pCa50  (C,  con-
trol minus PP1 + PKA; PP1, PP1 minus PP1 +   
PKA). *, P < 0.05. n = 7. PKA treatment did 
not significantly affect maximal force or nH 
(see Table II). (C; Left) Comparison of Ca
2+ 
sensitization as indexed by the shift of pCa50 
after PP1 treatment and cTn or PCRF recon-
stitution in PLV. (Right) Comparison of the 
PKA-induced shift of pCa50 in PP1-treated and 
cTn-  or  PCRF-reconstituted  PLV.  Statistical 
significance was not observed between groups 
in either graph.
TA B L E   I I I
Summary of the values of maximal active force and nH before and after 
PKA treatment in RP after reconstitution with cTn or PCRF
Maximal force 
(mN/mm
2)
nH
Fig. 4 B
Control RP 179.71 ± 7.04 4.47 ± 0.15
cTn 157.86 ± 4.30
a 3.00 ± 0.12
a
cTn + PKA 157.57 ± 4.22
a 3.07 ± 0.15
a
sTn 171.86 ± 5.18
b,c 4.71 ± 0.36
b,c
Fig. 5 C
Control RP 182.14 ± 7.98 4.50 ± 0.17
PCRF 158.14 ± 5.84
a 3.20 ± 0.25
a
PCRF + PKA 157.03 ± 5.71
a 3.13 ± 0.23
a
sTn 174.43 ± 5.05
b,c 4.42 ± 0.16
b,c
Maximal force was obtained by activating muscle at pCa 4.5 before plotting 
of the force-pCa curve at each condition.
aP < 0.05 compared with the corresponding values for control RP (before 
thin filament reconstitution).
bP  <  0.05  compared  with  the  corresponding  values  for  thin  filament 
reconstitution (before PKA treatment).
cP  <  0.05  compared  with  the  corresponding  values  for  PKA  treatment 
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reconstitution almost completely restored Ca
2+ sensitivity 
to the original level before PCRF reconstitution. As with 
cTn reconstitution, maximal force and nH were decreased 
by PCRF reconstitution, but not by PKA treatment, and 
both were restored with sTn reconstitution to levels not 
significantly different than those obtained before PCRF 
reconstitution (Table III).
D I S C U S S I O N
The goal of this study was to provide direct evidence 
that PKA-based phosphorylation of cTnI has the potential 
to decrease myofibrillar Ca
2+ sensitivity associated with 
cTnC in different types of the striated muscle sarco-
mere. To test this, we investigated whether PKA induces 
Ca
2+ desensitization in PLV and RP muscles, by using 
thin filament reconstitution. We demonstrated that PKA- 
dependent cTnI phosphorylation decreased Ca
2+ sensi-
tivity not only in PLV, but also in RP after reconstitution 
completely replaced cTnI with sTnI, and the ratio of 
sTnT or sTnI to actin was similar to that observed in 
control RP before PCRF reconstitution (sTn reconstitu-
tion ratio after PCRF reconstitution: sTnI, 107.04 ± 10.54%; 
sTnT, 85.97 ± 11.76%; residual cTnI, 0%; n = 6).
As shown in the chart recording (Fig. 5 B), submaxi-
mal forces (at pCa 6.0 and 5.75) were decreased upon 
PCRF  treatment  by  a  magnitude  greater  than  that  of 
maximal force, resulting in a decrease in the percentage 
to the maximum. PKA treatment further decreased sub-
maximal forces with little or no change in maximal force. 
Finally, sTn reconstitution restored submaximal forces to 
levels similar to those obtained before PCRF reconstitu-
tion, accompanied by a slight increase in maximal force.
Force-pCa curves in Fig. 5 C show that Ca
2+ sensitivity is 
decreased by 0.13 ± 0.02 pCa units with PCRF reconstitu-
tion, and it is further decreased by 0.10 ± 0.02 pCa units 
with PKA treatment, which is similar to what was observed 
in cTn reconstitution in RP (see Fig. 4 B). Also, sTn 
Figure 4.  Effect of PKA on Ca
2+ sensitivity in cTn-reconstituted RP. (A) Typical chart recording showing force-pCa protocols. A fiber 
was treated with cTn, PKA, and sTn, in this order (see Terui et al., 2008 for exchange ratio of Tn subunits under the same condition; 
i.e., 50% with cTn reconstitution). Green arrows (blue arrows) indicate percentage of force at pCa 6.0 (pCa 5.75) compared with the 
maximum obtained at the end of each force-pCa protocol. (B) Force-pCa curves showing the effects of cTn reconstitution, PKA treat-
ment, and sTn reconstitution on Ca
2+ sensitivity in RP. Black solid line, control with no treatment; gray solid line, cTn reconstitution; red 
solid line, PKA treatment; black dashed line, sTn reconstitution. (Inset) Summary of pCa50 values. *, P < 0.05 compared with control; #, 
P < 0.05 compared with cTn reconstitution; †, P < 0.05 compared with PKA. n = 9. (C) Force-pCa curves showing the effect of PKA on 
Ca
2+ sensitivity in RP with no Tn reconstitution. (Inset) pCa50 values before and after PKA treatment. Maximal force: 175.35 ± 6.32 and 
176.25 ± 5.31 mN/mm
2 (P > 0.05) before and after PKA, respectively; nH: 4.61 ± 0.34 and 4.67 ± 0.30 (P > 0.05) before and after PKA, 
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kinases (Pak) (e.g., Layland et al., 2005). Despite con-
flicting  reports  regarding  the  physiological  effects  of 
PKC-based phosphorylation of cTnI at Ser43/45 (and 
Thr144), an emerging consensus based on recent find-
ings is that Ser43/45 phosphorylation reduces maximal 
Ca
2+-activated  force,  and  in  concert  with  Thr144 
phosphorylation, it reduces maximal sliding velocity in 
in vitro motility assays (Layland et al., 2005). PKG phos-
phorylates cTnI at Ser23/24 at a 100-fold slower rate 
than PKA, with a physiological effect similar to that   
by PKA (Blumenthal et al., 1978; Yuasa et al., 1999;   
Layland  et  al.,  2005).  Pak  reportedly  phosphorylates 
cTnI at Ser149, resulting in an increase (not a decrease) 
in Ca
2+ sensitivity with no change in maximal force   
(Buscemi et al., 2002). Also, cTnT, but not sTnT, is 
phosphorylated by PKC in the C-terminal half of this 
molecule  (Solaro  and  Rarick,  1998).  However,  PKC-
based cTnT phosphorylation does not reportedly influ-
ence Ca
2+ sensitivity (Noland et al., 1995). Collectively, 
it is likely that PKA-dependent phosphorylation of cTnI 
at Ser23/24 is predominant in Ca
2+ desensitization among 
the various phosphorylation sites in cTnI and cTnT.
Reconstitution with cTn (Terui et al., 2008) or PCRF 
in PLV slightly but significantly increased Ca
2+ sensitivity 
(Fig. 2, C and D). Because cTnI Ser23/24 phosphoryla-
tion was less in cTn- or PCRF-reconstituted PLV than 
in control PLV (Fig. 2 B), the Ca
2+ sensitization may 
result at least in part from lowering of the background 
with the cTn complex. Moreover, the Ca
2+-desensitizing 
effect  was  independent  of  the  TnT  isoform  in  both 
types of muscle. The present findings are summarized 
in Table IV.
In both cardiac and skeletal sarcomeres, TnT is the 
largest component of the Tn complex. Within the cTn 
complex, the N-terminal half of cTnT anchors the com-
plex to Tm, and the C-terminal half forms a complex 
with cTnC, cTnI, and Tm (e.g., Solaro and Rarick, 1998; 
Ohtsuki and Morimoto, 2008). Despite extensive regions 
of  homology  among  the  various  forms  of  cTnT  and 
sTnT, there are important regions of structural diver-
sity, especially in the N-terminal region, which is highly 
charged and essentially absent in sTnT (Solaro and Rar-
ick, 1998). In the present study, however, we found that 
the force-pCa curve was shifted leftward (rightward) by 
a similar magnitude upon cTn and PCRF reconstitution 
in PLV (in RP) (Fig. 2, C and D, PLV, and Figs. 4 B and 
5 C, RP). Therefore, the TnT isoform variance of adult 
ventricular versus adult fast skeletal isoform is unlikely 
to account for the altering of Ca
2+ sensitivity, as demon-
strated earlier in rat (Chandra et al., 2006). Rather, it is 
likely that the “on–off” equilibrium of the thin filament 
state is more strongly governed by the TnC–TnI interac-
tion within the Tn molecule.
cTnI is phosphorylated not only by PKA, but also by 
other kinases, such as various types of PKC, cGMP-
dependent  protein  kinase  (PKG),  and  p21-activated 
Figure  5.  Effect  of  PKA  on  Ca
2+  sensitiv-
ity in PCRF-reconstituted RP. (A; Left) 15% 
gel showing reconstitution of RP with PCRF. 
Cont.,  control  fibers;  PCRF,  PCRF-reconsti-
tuted  fibers;  PCRF-sTn,  PCRF-reconstituted 
fibers  treated  with  sTn;  LC-3,  myosin  light 
chain 3. For other abbreviations, see legend 
to Fig. 2 A. (B) Typical chart recording show-
ing force-pCa protocols. A fiber was treated 
with PCRF, PKA, and sTn, in this order. Green 
arrows (blue arrows) indicate percentage of 
force at pCa 6.0 (pCa 5.75) compared with 
the maximum obtained at the end of each 
force-pCa  protocol.  (C)  Force-pCa  curves 
showing the effects of PCRF reconstitution, 
PKA treatment, and sTn reconstitution in RP. 
Black solid line, control with no treatment; 
gray solid line, PCRF reconstitution; red solid 
line, PKA treatment; black dashed line, sTn 
reconstitution.  (Inset)  Summary  of  pCa50 
values.  *,  P  <  0.05  compared  with  control; 
#, P < 0.05 compared with PCRF; †, P < 0.05 
compared with PKA. n = 10.  Matsuba et al. 579
but the effects were not significant in PLV (Table II). 
This suggests that the cTnI–cTnC complex shifts the 
equilibrium of the thin filament state toward the “off” 
state to a relatively greater degree than its fast skeletal 
counterpart (Terui et al., 2008; Fukuda et al., 2009). In 
fact, upon sTn reconstitution, both maximal force and 
nH were restored to levels not significantly different than 
those obtained before reconstitution in RP (Table III). 
PKA  treatment,  however,  decreased  Ca
2+  sensitivity   
with no change in maximal force or nH in both RP 
(Table III) and PLV (Tables I and II), suggesting a dif-
ferent mode of action between Tn reconstitution and 
PKA treatment in the thin filament regulation. We con-
sider that Tn reconstitution can potentially alter the 
near-neighbor regulatory unit interactions within thin 
filaments (see Terui et al., 2008), whereas PKA-based 
Ser23/24 phosphorylation in cTnI simply reduces Ca
2+ 
binding to cTnC with no change in signaling between 
neighboring regulatory units. Clearly, future studies are 
needed to clarify the differences in the effects between 
isoform switching of Tn subunits and phosphorylation 
by various kinases.
The magnitude of Ca
2+ desensitization by PKA in cTn- 
or PCRF-reconstituted RP was 0.1 pCa units (Figs. 4 B 
and 5 C), 50% of the effect observed in reconstituted 
PLV (Fig. 2, C and D). This is probably due to the fact 
that in RP the thin filament reconstitution ratio with 
either cTn or PCRF cannot technically exceed 50% to 
avoid irreversible damages to the regulatory system (see 
Terui et al., 2008), whereas in PLV thin filament reconsti-
tution can be achieved by 100% with cTn or PCRF (see 
Terui et al., 2008 and Fig. 2 A). Given the finding that the 
magnitude of PKA-based Ca
2+ desensitization is linearly 
correlated to the amount of cTnI (Fig. 1 D), it can be 
considered that the magnitude of Ca
2+ desensitization is 
similar in both PLV and RP; i.e., by potentially 0.2 pCa 
units with a full amount of the cTnI–cTnC complex.
One may point out that MyBP-C phosphorylation has 
to be taken into account in the interpretation of the 
data on PLV due to its potential impact on Ca
2+ sensitiv-
ity. MyBP-C, a large protein associated with the thick fil-
ament of striated muscle, constrains cross-bridges to the 
thick filament backbone (see Granzier and Campbell, 
phosphorylation of these residues. Consistent with this 
view, PP1 treatment reduced the cTnI phosphorylation 
level (Fig. 3 A) and increased Ca
2+ sensitivity (Fig. 3 B). 
Therefore, the Ca
2+ sensitization after cTn or PCRF re-
constitution and PP1 treatment in PLV may result pre-
dominantly  from  dephosphorylation  of  Ser23/24  in 
cTnI.  This  is  supported  by  the  finding  that  PKA  in-
creased cTnI phosphorylation (Figs. 2 B and 3 A) and 
caused a similar magnitude of Ca
2+ desensitization after 
cTn or PCRF reconstitution and PP1 treatment (Fig. 3 C), 
with a position of the force-pCa curve similar to that of 
control PLV after PKA treatment (Fig. 1 B).
This study revealed that RP became respondent to PKA 
treatment  showing  Ca
2+  desensitization  after  thin  fila-
ments had been reconstituted with cTn (Fig. 4, A and B) 
or PCRF (Fig. 5, B and C). Because in a control experi-
ment PKA failed to alter Ca
2+ sensitivity in RP without 
thin filament reconstitution (Fig. 4 C), the Ca
2+-desensi-
tizing effect after cTn or PCRF reconstitution likely results 
from Ser23/24 phosphorylation in cTnI and subsequent 
reduction in the affinity of cTnI for cTnC, as well as in 
the affinity of cTnC for Ca
2+. This interpretation is sup-
ported by the result that subsequent treatment with sTn 
after PKA treatment (100% reconstitution for PCRF 
[Fig. 5 A] as well as for cTn [Terui et al., 2008]) almost 
completely restored Ca
2+ sensitivity to the original level. 
It is also worthwhile noting that the magnitude of the 
PKA-induced  shift  of  pCa50  was  similar  with  cTn  and 
PCRF reconstitution not only in PLV (Fig. 2, C and D), 
but also in RP (Figs. 4 B and 5 C). Howarth et al. (2007) 
proposed that there are “extended” and “bent” confor-
mations in Tn (see Solaro et al., 2008); phosphorylation 
or dephosphorylation at Ser23/24 in cTnI modulates the 
equilibrium between the two conformations (“bent” with 
phosphorylation), similar to that proposed for regula-
tion of smooth muscle myosin by phosphorylation at the 
N terminus of the regulatory light chain. It is therefore 
suggested that the phosphorylation-induced “bending” 
and the ensuing reduction in Ca
2+ sensitivity occur 
regardless of the TnT isoform; viz., regardless of the pres-
ence or absence of the N-terminal extension of TnT.
cTn or PCRF reconstitution significantly decreased 
maximal Ca
2+-activated force and nH in RP (Table III), 
TA B L E   I V
Summary of this work describing whether PKA exerts its Ca
2+-desensitizing effect in PLV and RP with various combinations of Tn subunits
Muscle type
PLV RP
Original Reconstituted  
(cTn)
Reconstituted 
(PCRF)
Reconstituted  
(sTn)
Original Reconstituted  
(cTn)
Reconstituted 
(PCRF)
TnI-TnC complex C C C S S C C
TnT C C S S S C S
Ca
2+ desensitization 
(+PKA)
+ + +   + +
 “C” and “S” indicate that the Tn subunit (or the complex) is of cardiac or fast skeletal origin, respectively. +, Ca
2+ desensitization present; , Ca
2+ 
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2006;  Oakley  et  al.,  2007  and  references  therein).  A 
binding site for the light meromyosin domain of myosin 
is present near the C terminus of MyBP-C, and a second 
site that binds the S2 domain of myosin is present near 
the N terminus of MyBP-C. The cardiac MyBP-C isoform 
contains PKA phosphorylation sites within the S2 bind-
ing site that are absent in skeletal isoforms. A recent 
study demonstrated that the primary effect of MyBP-C 
phosphorylation is to accelerate the cross-bridge cycling 
rate, and that of cTnI phosphorylation is to reduce Ca
2+ 
sensitivity (Stelzer et al., 2007). Our findings that PKA 
exerted no effect on Ca
2+ sensitivity after sTn reconstitu-
tion in PLV (Fig. 1 C), despite clear enhancement of 
MyBP-C phosphorylation (Fig. S1), appear to be consis-
tent with the conclusion of the work by Stelzer et al. 
(2007). It is therefore safe to consider that the PKA-in-
duced Ca
2+ desensitization in PLV is not modulated by 
MyBP-C  phosphorylation,  with  and  without  thin  fila-
ment reconstitution.
We performed all of the mechanical experiments at SL 
2.0 µm, where passive force was barely produced in both 
PLV and RP. In PLV at longer SL, the decrease in titin-
based passive force via PKA-dependent phosphorylation 
of the N2B segment may weaken titin’s effect on the acto-
myosin interaction (e.g., Cazorla et al., 2001; Fukuda 
et al., 2001a, 2003), resulting presumably in the enhance-
ment of Ca
2+ desensitization. However, this possible SL 
dependence is unlikely to occur in RP due to the absence 
of the N2B segment (e.g., Prado et al., 2005).
In conclusion, this study for the first time directly 
demonstrated that PKA-dependent cTnI phosphoryla-
tion universally causes Ca
2+ desensitization in cardiac 
and fast skeletal sarcomeres, in association with cTnC. 
Future studies are warranted to investigate whether or 
not the mechanical properties are altered in response 
to -adrenergic stimulation in intact skeletal muscle ex-
pressed with the cTnI–cTnC complex.
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